Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease

Bacterial enteric pathogens have evolved efficient mechanisms to suppress mammalian inflammatory and immunoregulatory pathways. By exploiting the evolutionary relationship between the gut and pathogenic bacteria, we have developed a potential mucosal therapeutic. Our findings suggest that engineered...

Full description

Saved in:
Bibliographic Details
Published inACS nano Vol. 11; no. 10; pp. 9650 - 9662
Main Authors Herrera Estrada, Lina, Wu, Huixia, Ling, Kevin, Zhang, Guikai, Sumagin, Ronen, Parkos, Charles A, Jones, Rheinallt M, Champion, Julie A, Neish, Andrew S
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 24.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bacterial enteric pathogens have evolved efficient mechanisms to suppress mammalian inflammatory and immunoregulatory pathways. By exploiting the evolutionary relationship between the gut and pathogenic bacteria, we have developed a potential mucosal therapeutic. Our findings suggest that engineered preparations of the Salmonella acetyltransferase, AvrA, suppress acute inflammatory responses such as those observed in inflammatory bowel disease (IBD). We created 125 nm diameter cross-linked protein nanoparticles directly from AvrA and carrier protein to deliver AvrA in the absence of Salmonella. AvrA nanoparticles are internalized in vitro and in vivo into barrier epithelial and lamina propria monocytic cells. AvrA nanoparticles inhibit inflammatory signaling and confer cytoprotection in vitro, and in murine colitis models, we observe decreased clinical and histological indices of inflammation. Thus, we have combined naturally evolved immunomodulatory proteins with modern bioengineering to produce AvrA nanoparticles, a potential treatment for IBD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
L.H.E., H.W., and K.L. contributed equally.
Department of Pathology, University of Michigan Health System, 5240 MSI, SPC 5602, Ann Arbor, MI 48109.
Present Address: Department of Pathology, Northwestern University Feinberg School of Medicine, Tarry Building Room 3-707, 300 E Superior, Chicago, IL 60611.
ISSN:1936-0851
1936-086X
DOI:10.1021/acsnano.7b03239